JPS60108052A - Hollow yarn type serum separation membrane - Google Patents

Hollow yarn type serum separation membrane

Info

Publication number
JPS60108052A
JPS60108052A JP21754383A JP21754383A JPS60108052A JP S60108052 A JPS60108052 A JP S60108052A JP 21754383 A JP21754383 A JP 21754383A JP 21754383 A JP21754383 A JP 21754383A JP S60108052 A JPS60108052 A JP S60108052A
Authority
JP
Japan
Prior art keywords
membrane
separation membrane
hollow fiber
plasma
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP21754383A
Other languages
Japanese (ja)
Other versions
JPH0440060B2 (en
Inventor
充 鈴木
高橋 一二三
南 孝久
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP21754383A priority Critical patent/JPS60108052A/en
Publication of JPS60108052A publication Critical patent/JPS60108052A/en
Publication of JPH0440060B2 publication Critical patent/JPH0440060B2/ja
Granted legal-status Critical Current

Links

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 本発明は中空糸型血漿分離膜に関するものであり、さら
に詳しくは血液処理用膜として要求されるに充分な機械
的強度をもち、かつ優れた血漿透過性を同時に有し2、
シかも抗溶血性を有する中空糸型血漿分離膜に関するも
のである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a hollow fiber plasma separation membrane, and more specifically to a hollow fiber plasma separation membrane that has sufficient mechanical strength required as a blood processing membrane and also has excellent plasma permeability. 2,
The present invention also relates to a hollow fiber plasma separation membrane having anti-hemolytic properties.

膜を利用する血漿分離は、薬物中毒・劇症肝炎等の患者
の血漿を正常な血漿と短時間のうちに交換する場合や血
漿中の特定溶質分離の為の前処理操作令等に利用されて
いる。いずれの場合も全血を中空糸型血漿分離膜の中空
内部に供給し外壁より濾出させ血漿成分を分離するもの
である。
Plasma separation using membranes is used when the plasma of patients with drug poisoning, fulminant hepatitis, etc. is exchanged with normal plasma in a short period of time, and for pretreatment procedures for separating specific solutes in plasma. ing. In either case, whole blood is supplied to the hollow interior of a hollow fiber plasma separation membrane and filtered out through the outer wall to separate plasma components.

かかる血漿分離を行なうにあたり使用する膜に要求され
る性能として、血球成分と血漿成分とを効率よく分離す
る性能と医療器具としての安全性能が重要なものとして
挙げられる。この安全性能には物理的衝撃に耐えられる
力学的強度の保証や抗溶血性がある。この力学的強度の
保証が必要とされるのは次の理由による。即ち1血漿分
離モジュールは使用直前に生理食塩水で洗浄をかねたプ
ライミングが必要であり1更に完全脱泡を行なう。
Important performances required of the membrane used for such plasma separation include the ability to efficiently separate blood cell components and plasma components and safety performance as a medical device. This safety performance includes guaranteeing mechanical strength to withstand physical impact and anti-hemolytic properties. The reason why this guarantee of mechanical strength is required is as follows. That is, 1. the plasma separation module requires priming, which also includes washing with physiological saline, immediately before use, and 1. complete defoaming.

この脱泡時モジュールに物理的衝撃を加えないと完全な
脱泡を行なうことがむつかしい。実際には鉗子でモジュ
ールを叩く手段を採用している。さらにモジュールに物
理的衝撃が加えられるのはモジュール輸送時にもおこる
。との様な衝撃が分離膜に加えられると充分な機械的強
度を有していないものなら膜が破損し、中空糸内部に導
入した血液が中空糸壁を通してリークし重大なトラブル
を派生することになるからである。また抗溶血性につい
ては溶血後赤血球内部から放出されるヘモグロビンが生
体にとって有害であるという理由によっている。
During defoaming, it is difficult to completely defoam unless a physical impact is applied to the module. In reality, a method of hitting the module with forceps is used. Furthermore, physical shocks are applied to modules during module transport. If such an impact is applied to the separation membrane, the membrane will be damaged if it does not have sufficient mechanical strength, and the blood introduced inside the hollow fiber will leak through the hollow fiber wall, causing serious trouble. This is because it becomes The anti-hemolytic property is based on the fact that hemoglobin released from the inside of red blood cells after hemolysis is harmful to living organisms.

従来より血漿分離に用いられてきた中空糸型分離Iff
はに述の血液リークに関するトラブルを未然に回避する
ため膜厚の大きいものが採用されてきた。例えば@厚が
100μmを超える分離膜が採用されており、従って破
断強度は90f以上でリークについてはあまり間賄がお
こらなかった。しかしながら1膜厚が大きくなる分だけ
濾過抵抗が上昇するので血漿透過性が低くなるという欠
点が惹起される。この血漿透過性(血球成分と血漿成分
とを効率よく分離する性能)が低いと血漿交換、血漿採
取に長時間を要し患者に肉体的蔦精神的負担を与えるこ
とになるので、この性能が高められた膜を得ることは先
述の血液リークのない膜を作製することと同程度に重要
になる。
Hollow fiber separation If has traditionally been used for plasma separation
In order to avoid the above-mentioned troubles related to blood leakage, a film with a large thickness has been used. For example, a separation membrane with a thickness exceeding 100 μm was used, so the breaking strength was 90 f or more, and leakage did not occur much. However, as the membrane thickness increases, the filtration resistance increases, resulting in a lower plasma permeability. If this plasma permeability (the ability to efficiently separate blood cell components and plasma components) is low, plasma exchange and plasma collection will take a long time, which will place a physical and mental burden on the patient. Obtaining an enhanced membrane becomes as important as creating a blood leak-free membrane as mentioned above.

むろんこの血漿透過性を高め得る分離膜についても種々
検討されている。例えば中空糸膜の内外壁面の開孔率を
高め飄濾過に有効な大きな孔面積を有する膜が試作され
てはいるが1この場合は血漿分離性能が大きくなる分だ
け逆に機械的強度が下がり、前述の血液リークについて
の重大トラブルをひきおこすという欠点が惹起される。
Of course, various separation membranes that can increase plasma permeability are also being studied. For example, a membrane with a large pore area that is effective for filtration by increasing the porosity of the inner and outer walls of a hollow fiber membrane has been prototyped.1 However, in this case, the mechanical strength decreases as the plasma separation performance increases. However, this method has the disadvantage of causing the serious problem of blood leak mentioned above.

る技術課題とは相矛盾した性格のものであって1両者を
同時に満足する中空糸型血漿分離膜は現状では得られて
いなかった。
These technical problems are contradictory, and a hollow fiber plasma separation membrane that satisfies both of them at the same time has not yet been obtained.

而して本発明者等は、これらの性能を同時に具備せる中
空糸型血漿分離膜について鋭意研究した結果、中空糸の
壁厚を薄くしても膜に特異な多孔即ち、本発明は中空糸
型血漿分離膜であって1該膜の外壁面は孔面積1.3 
X 10””s+−以下の孔が開孔率40%以下で平均
に分散して形成され1まだ内壁面は孔面積1,8 X 
lcI”−以下の孔が開孔率60%以上で網目状に形成
されてなり\かつ上起膜の壁厚が100μ爾以下である
中空糸型血漿分離膜である。
As a result of intensive research into hollow fiber plasma separation membranes that simultaneously provide these performances, the present inventors found that even if the wall thickness of the hollow fibers is thinned, the membrane's unique porosity, that is, the hollow fibers of the present invention. type plasma separation membrane, and the outer wall surface of the membrane has a pore area of 1.3
X 10""s+- or less pores are formed evenly distributed with a porosity of 40% or less, and the inner wall surface has a pore area of 1.8 X
This is a hollow fiber plasma separation membrane in which pores of 1cI" or less are formed in a network with a porosity of 60% or more, and the wall thickness of the upper membrane is 100μ or less.

本発明に係る血漿分離膜(後述の実施例)の内1外壁面
の亀子顕微鏡写真(倍率5000倍)の−例を第1図(
内面)及び第2図(外面)に示す。
An example of a Kameko micrograph (magnification: 5000x) of the inner and outer walls of the plasma separation membrane according to the present invention (examples described below) is shown in Figure 1 (
(inner surface) and Figure 2 (outer surface).

本発明にいう孔面積、開孔率はこの電顕写真より次の方
法で実測した値である。
The pore area and pore area ratio referred to in the present invention are values actually measured from this electron micrograph using the following method.

(1)白馬外壁面の孔面積(md) 5000倍の電顕
写真の観察を行ない)内、外壁面の最大の孔面積で規定
(1) Hole area (md) of the outer wall of Hakuba Observed using an electron micrograph at 5000x magnification) Defined by the largest pore area of the inner and outer wall.

(2)内1外壁面の開孔率(%)5o o o倍の電顕
写真の観察を行ない)5X5−の単位面積当りの膜孔の
占める総面積の割合で規定。
(2) Porosity ratio (%) of inner and outer wall surfaces Observed by electron micrographs magnified 5×5−) Defined as the ratio of the total area occupied by membrane pores per unit area of 5×5−.

実際には次の様にしてめる。Actually, it can be done as follows.

 I OO 本発明では血漿分離膜の外壁面は上述の様にしてめられ
る孔thi積及び開孔率が1,3 X 10”−以下及
び40%以下であること、かつ内壁面は孔面積1・8X
IO”” −以下の孔が開孔率60%以上で網目状に形
成されてなることが必要である。内壁面は本発明の範囲
にあっても孔面積1.3 X 10−2 mを越える孔
が40%以下で開孔する膜又は孔面積1.3 X 10
″4−以下の孔が40tIIを越える割合で開孔する膜
は機械的強度が低下するので望ましくなする膜も機械的
強度が低下する点で好ましくなく1孔面積1,13 X
 10″J−以下の孔が60%未満で開孔する膜は分離
能が下がるので望ましくなしA0本発明では上述の様に
膜に特異な多孔構造力(形成されるため得られる膜に充
分な機械的性質が付与される。
I OO In the present invention, the outer wall surface of the plasma separation membrane has a pore area of 1.3 x 10" or less and a porosity of 40% or less, and the inner wall surface has a pore area of 1.・8X
It is necessary that pores of IO"" or less be formed in a network shape with a porosity of 60% or more. Even if the inner wall surface is within the scope of the present invention, the membrane has a pore area of 1.3 x 10-2 m or less, with 40% or less of the pores exceeding 1.3 x 10-2 m.
A membrane in which pores of 4 or less are opened at a rate exceeding 40tII is desirable because its mechanical strength decreases, but it is also undesirable because its mechanical strength decreases.
A membrane in which less than 60% of pores of 10"J- or less are open is undesirable because the separation performance decreases. Mechanical properties are imparted.

しかも驚くべきことに上述の様な表面非対様構造を有す
る中空糸型血漿分離膜は良好な力学的特性に基因して壁
厚を薄くしても血液リークに何等問題が生じない。即ち
)壁厚100μ鶏以下のものが得られ、以って血漿分離
性能も著しく高め得ることかできた。
Surprisingly, the hollow fiber plasma separation membrane having the above-mentioned surface asymmetrical structure has good mechanical properties, so even if the wall thickness is made thin, no problem arises regarding blood leakage. That is, a membrane with a wall thickness of 100 μm or less was obtained, and thus the plasma separation performance could be significantly improved.

かかる中空糸型血漿分離膜は例えば高分子化合物を溶剤
及び膨潤剤に溶解させ、これを中空状に紡糸し該溶剤及
び膨潤剤を含有する水性凝固浴に浸漬すると同時に中空
糸内部にも該溶剤及び膨潤剤を含有する水性凝固液を導
入し1内蔦外部を凝固させる中空糸型血漿分離膜の製造
法において1中空糸内部に導入する凝固液中の溶剤及び
膨潤剤の濃度(OX重鼠%)及び中空糸外部の凝固浴中
の溶剤及び膨潤剤の濃度(a9重量%)の間に0.−0
1(−Δ0)を2〜20重鼠%の範囲にコントロールす
ることに得られる。
Such a hollow fiber plasma separation membrane is produced by, for example, dissolving a polymer compound in a solvent and a swelling agent, spinning it into a hollow fiber, and immersing it in an aqueous coagulation bath containing the solvent and swelling agent. In a method for manufacturing a hollow fiber plasma separation membrane in which an aqueous coagulating solution containing a swelling agent is introduced to coagulate the outside of one hollow fiber, the concentration of the solvent and swelling agent in the coagulating solution introduced into one hollow fiber (OX heavy mouse %) and the concentration of the solvent and swelling agent in the coagulation bath outside the hollow fiber (a9% by weight). -0
This can be obtained by controlling 1(-Δ0) within the range of 2 to 20%.

上述の製造方法において高分子化合物としてセルロース
エステル(セルロースジアセテート、セルローストリア
セテート、硝酸セルロース等)等又浴剤としてN−メチ
ル−2−ピロリドン1ジメチルホルムアミド等、さらに
膨潤剤としてポリエチレングリフール(平均分子型20
0〜1ooo )等が使用される。中空糸内部に導入す
る凝固液の溶剤及び膨潤剤の量と中空糸外部に存在せし
める凝固浴の溶剤及び膨潤剤の量とに差を設けることに
よりはじめて前述した如く構造を有する血漿分離膜が作
製された。
In the above production method, polymer compounds such as cellulose esters (cellulose diacetate, cellulose triacetate, cellulose nitrate, etc.), bath agents such as N-methyl-2-pyrrolidone-1-dimethylformamide, and swelling agents such as polyethylene glyfur (average molecular Type 20
0~1ooo) etc. are used. A plasma separation membrane having the structure described above can only be produced by creating a difference between the amount of solvent and swelling agent in the coagulation solution introduced into the hollow fiber and the amount of solvent and swelling agent in the coagulation bath present outside the hollow fiber. It was done.

また本発明に係る分離膜は内壁面に網目状の孔が形成さ
れるので抗溶血性にも優れている。即ち1赤面球を網目
のフィブリル線上でささえることができ1保持される部
分の下部に血漿の流れをもたせ軸方向への移動を容易に
させることができるためである。
Furthermore, since the separation membrane according to the present invention has mesh-like pores formed on the inner wall surface, it also has excellent anti-hemolytic properties. That is, the red sphere can be supported on the fibril lines of the mesh, and the flow of blood plasma can be caused below the part where the sphere is held, facilitating movement in the axial direction.

この様に本発明に係る中空糸型血漿分離膜は血液処理用
膜として要求されるに充分な機械的強度をもち、かつ優
れた血漿透過性を同時に有し1しかも良好な抗溶血性も
具備するものであって1今後医療分野に大きく貢献でき
るものである。
As described above, the hollow fiber plasma separation membrane according to the present invention has sufficient mechanical strength required as a blood processing membrane, has excellent plasma permeability, and also has good anti-hemolytic properties. 1 It is something that can greatly contribute to the medical field in the future.

以下本発明の実施例を記載するが1本発明はこれら実施
例に限定されるものでない。
Examples of the present invention will be described below, but the present invention is not limited to these Examples.

実施例 1、 次の様にして膜厚82μ講の血漿分離膜を製造した。Example 1, A plasma separation membrane having a thickness of 82 μm was manufactured in the following manner.

紡糸原液;セルローストリアセテート30重量%を、N
−メチル−2−ピロリドン 及びポリエチレングリコール(400)を重鼠比で6:
4に混合して得た混 合溶媒に溶解。
Spinning stock solution: 30% by weight of cellulose triacetate, N
-Methyl-2-pyrrolidone and polyethylene glycol (400) in a heavy ratio of 6:
Dissolved in the mixed solvent obtained by mixing 4.

紡 出;上記紡糸原液を121℃に加熱後、83℃にて
ノズルから紡出1空気を 通過させて凝固浴に導く。紡出時中 空糸内部には凝固液を導入する。
Spinning: After heating the above-mentioned spinning dope to 121°C, spinning air is passed through a nozzle at 83°C to lead to a coagulation bath. A coagulating liquid is introduced into the hollow fiber during spinning.

凝 固;凝固液(中空糸内液)としてN−メチル−2−
ピロリドン及びポリエチ レングリコール(4oo)を70重 量%含有する水溶液、又凝固浴(中 空糸外部)としてN−メチル−2− ピロリドン及びポリエチレングリコ ール(400)を74.3重量%含有 する水溶液を凝固。
Coagulation: N-methyl-2- as coagulation liquid (hollow fiber internal liquid)
An aqueous solution containing 70% by weight of pyrrolidone and polyethylene glycol (4oo), and an aqueous solution containing 74.3% by weight of N-methyl-2-pyrrolidone and polyethylene glycol (400) as a coagulation bath (outside the hollow fiber) were coagulated.

後処理;凝固後、水洗し、しかる後50℃−90容凰%
のグリセリン浴で1時間 処理して乾燥する。
Post-treatment: After solidification, washing with water, then 50℃-90% by volume
Treat in a glycerin bath for 1 hour and dry.

得られた中空糸型分離膜は第1図、第2図の如く構造を
有する。かかる膜の諸特性は第1表の如くであった。
The obtained hollow fiber separation membrane has a structure as shown in FIGS. 1 and 2. The properties of this film were as shown in Table 1.

第 1 表 破断時の荷重で示す。Table 1 Shown as the load at break.

帝杓次の式マ求まる量 限界濾過割合−(分離血漿流澁)/(供給血液流血)1
00 (ただしHt−38%、供給血液流量1009−)尚1
公知の2種の血漿分離膜について前記と同じ特性を測定
した結果は第2表の如くであった。
Calculate the following formula: Critical filtration rate - (separated plasma flow rate) / (supply blood flow rate) 1
00 (However, Ht-38%, supply blood flow rate 1009-) Note 1
Table 2 shows the results of measuring the same characteristics as above for two known types of plasma separation membranes.

第 2 表Table 2

【図面の簡単な説明】[Brief explanation of drawings]

第1図、第2図は本9自明の血漿分離膜の市、子顕微譚
写真を示1゜内壁1+j i、J第]図に、外壁面は第
2図で示1゜ ’+ff ifi’出W1人 東洋紡績株式会社手 続
 補 正 書(自発) 昭和59年 5月10日 L 事件の表示 昭和58年特許願第217543号 2 発明の名称 中空糸型血漿分離膜 & 補正をする者 事件との関係 特許出願人 大阪市北区堂島浜二丁目2番8号 4 補正の対象 明細書の特許請求の範囲の欄及び発明の詳細な説明の欄 (2)明細11頁第17行目及び第19行目[1,3X
 I O−”−J及び「1.axlo−’sJJを「1
.3Xz o −’ x −vrtl J及び「1.8
 x l O−” x 7Jに6000 5000 訂正する@ (8)同第6頁第9行目〜第10行目「内、外壁面の最
大の孔面積で規定0」を「内、外壁面の最大の孔面積で
規定。即ち、内、外壁面の最大の孔面積を実測する(S
−)。5000倍の電顕写真からの実測ゆえこの実測面
iから真の孔面積をめるには次の様にすればよい。 真の孔面積(+a+J)−8x x Jに訂正する。 5000 5000 (4) 同第6頁最下行「x、3x1o−’−」を「1
.3X I O−’ X −vul Jに訂正する。 000 (5)同第6頁第2行目、第9行目及び第11行目「1
,8 xlo−’mj Jを[1,8X I O−” 
X−”−+ad J000 に訂正する。 (6) 同第6頁第4行目及び第6行目「1.5xxo
−”−」を「x、3x z o−2x Tn7−Jに訂
正する。 ()) 同第10頁第1表中の外壁面最大孔面積(−)
 「o、6x z o−1」 を [o、6 X I 
O−” x−’−−*** J000 に1又内壁面最大孔面積(−) 「1.5xx o−″
」を「1.5xlO””x ” Jに訂正する。 000 (8) 同第10頁下より第2行目と第3行目との間に
次の式を挿入する。 「瞭傘り実測孔面積x 5oooX 1111−= o
 、 s x x o −” x5000 ’ (9) 同第11頁第2表中の外壁面最大孔面積(−)
 「0.3X I O−” J及び「1.oxlo−”
 」を「0.3×10′″2×□」及び「l +OX 
10−” X−Jに、5000 5000 又内壁面最大孔面積(−) [o、a X 10−” 
J及び「5.0X10−’Jをl’−0,8xlO’″
″×−土−」及び15.0000 x l O−” ’ x−1−Jに各々訂正する。 000 別 紙 特許請求の範囲 膜の外壁面は孔面積1.3xl’O−”x ”−一以下
の000 孔が開孔率40%以下で平均に分散して形成され、また
膜の内壁面は孔面積1.8 X I O””X 1 −
以000 下の孔が開孔率6o%以上で網目状に形成されてなり、
かつ上記膜の壁厚が100μ胃以下である中空糸型血漿
分離膜。
Figures 1 and 2 show microscopic photographs of the plasma separation membrane which is self-explanatory in Book 9. 1゜inner wall 1+j i, J] figure, and the outer wall surface is shown in figure 2 1゜'+ff ifi' 1 applicant Toyobo Co., Ltd. Procedural amendment (voluntary) May 10, 1980 L Display of the case 1982 Patent Application No. 217543 2 Name of the invention Hollow fiber plasma separation membrane & amendment person case Relationship with Patent Applicant 2-2-8-4 Dojimahama, Kita-ku, Osaka City Claims column and Detailed Description of the Invention column (2) of the specification subject to amendment (2) Lines 17 and 11 of page 11 of the specification Line 19 [1,3X
I O-”-J and “1.axlo-’sJJ”
.. 3Xz o -' x -vrtl J and '1.8
x l O-" x 6000 5000 to 7J Defined by the maximum hole area.In other words, the maximum hole area of the inner and outer walls is actually measured (S
-). Since the actual measurement was taken from an electron micrograph with a magnification of 5,000 times, the true hole area can be calculated from this actual measurement surface i as follows. Correct to true pore area (+a+J)-8x x J. 5000 5000 (4) Change "x, 3x1o-'-" to "1" on the bottom line of page 6.
.. Correct to 3X I O-' X -vul J. 000 (5) Page 6, line 2, line 9, and line 11 “1
,8 xlo-'mj J [1,8X I O-''
X-”-+ad J000. (6) Page 6, lines 4 and 6 “1.5xxo
-"-" is corrected to "x, 3x z o-2x Tn7-J. ()) Maximum hole area of outer wall surface (-) in Table 1, page 10 of the same
"o, 6x z o-1" [o, 6 X I
O-"x-'--*** J000 Maximum hole area on inner wall (-) "1.5xx o-"
” is corrected to “1.5xlO””x ”J. 000 (8) Insert the following formula between the second and third lines from the bottom of page 10. "Actual measured hole area x 5oooX 1111-= o
, s x x o −” x5000 ' (9) Maximum pore area (-) on the outer wall surface in Table 2, page 11 of the same
"0.3X I O-" J and "1.oxlo-"
” to “0.3×10′″2×□” and “l +OX
10-" X-J, 5000 5000 Also, the maximum hole area on the inner wall surface (-) [o, a X 10-"
J and "5.0X10-'Jl'-0,8xlO'"
``×-Sat-'' and 15.0000 x l O-''' x-1-J. 000 pores of 1 or less are formed evenly distributed with a porosity of 40% or less, and the inner wall surface of the membrane has a pore area of 1.8
000 The lower pores are formed in a mesh shape with a porosity of 60% or more,
and a hollow fiber plasma separation membrane having a wall thickness of 100 μm or less.

Claims (1)

【特許請求の範囲】[Claims] 膜の外壁面は孔面積1,3 X 10”−以下の孔が開
孔率40%以下で平均に分散して形成され1また膜の内
壁面は孔面積1.8 X 10−” md以下の孔が開
孔率60%以上で網目状に形成されてなり、かつ上記膜
の壁厚が100μ諷以下である中空糸型血漿分離膜。
The outer wall surface of the membrane is formed of pores with a pore area of 1.3 x 10" m or less and an average distribution of pores with a porosity of 40% or less, and the inner wall surface of the membrane has a pore area of 1.8 x 10" md or less. A hollow fiber plasma separation membrane, wherein the pores are formed in a mesh shape with a porosity of 60% or more, and the wall thickness of the membrane is 100 μm or less.
JP21754383A 1983-11-17 1983-11-17 Hollow yarn type serum separation membrane Granted JPS60108052A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21754383A JPS60108052A (en) 1983-11-17 1983-11-17 Hollow yarn type serum separation membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21754383A JPS60108052A (en) 1983-11-17 1983-11-17 Hollow yarn type serum separation membrane

Publications (2)

Publication Number Publication Date
JPS60108052A true JPS60108052A (en) 1985-06-13
JPH0440060B2 JPH0440060B2 (en) 1992-07-01

Family

ID=16705900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21754383A Granted JPS60108052A (en) 1983-11-17 1983-11-17 Hollow yarn type serum separation membrane

Country Status (1)

Country Link
JP (1) JPS60108052A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60241904A (en) * 1984-04-13 1985-11-30 Teijin Ltd Hollow fiber-seaped porous membrane
CN102198373A (en) * 2011-05-10 2011-09-28 夏运成 Microporous filter membrane for rapidly collecting micro-serum and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60241904A (en) * 1984-04-13 1985-11-30 Teijin Ltd Hollow fiber-seaped porous membrane
JPH0376970B2 (en) * 1984-04-13 1991-12-09 Teijin Ltd
CN102198373A (en) * 2011-05-10 2011-09-28 夏运成 Microporous filter membrane for rapidly collecting micro-serum and preparation method thereof

Also Published As

Publication number Publication date
JPH0440060B2 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
JP3047403B2 (en) Permeation-selective asymmetric membrane suitable for hemodialysis and method for producing the membrane
US5496637A (en) High efficiency removal of low density lipoprotein-cholesterol from whole blood
US5187010A (en) Membrane having high affinity for low density lipoprotein-cholesterol from whole blood
AU660425B2 (en) High efficiency removal of low density lipoprotein-cholesterol from whole blood
US5418061A (en) Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol
JP5720249B2 (en) Hollow fiber membrane, method for producing the same, and blood purification module
JP3172542B2 (en) Filter material for capturing leukocytes and method for producing the same
JP2010233999A (en) Blood purifier
JP4873665B2 (en) Hollow fiber membrane for blood purification
JP2703266B2 (en) Polysulfone hollow fiber membrane and method for producing the same
JPS60108052A (en) Hollow yarn type serum separation membrane
JPH053335B2 (en)
JP2020533166A (en) Microporous membrane and its manufacturing method
JP4352709B2 (en) Polysulfone-based semipermeable membrane and artificial kidney using the same
JPH09308685A (en) Hollow fiber membrane for blood purification and blood purifying device
JP2805873B2 (en) Hollow fiber type plasma separation membrane
JP4381073B2 (en) Blood purification membrane with excellent blood compatibility
JP4381022B2 (en) Hollow fiber blood purification membrane
JPS63123403A (en) Polyacrylonitrile hollow yarn membrane and production thereof
JP2009078121A (en) Blood purifier and its production method
JPS6411322B2 (en)
JP2005065725A (en) Hollow fiber blood purifying membrane
JPS6247367A (en) Blood concentrator
JP2005074019A (en) Hollow fiber type blood purification membrane
JP5299617B2 (en) Method for producing hollow fiber membrane

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees